A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosis

BACKGROUND: Antiepidermal growth factor receptor (EGFR)-targeted therapy is widely used in many epithelial cancer types. We investigated lapatinib effects on cutaneous squamous cell carcinoma (cSCC) scheduled for resection and in coexisting precursor lesions (actinic keratosis (AK) and Bowen's...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenni, D, Karpova, MB, Mühleisen, B, Mangana, J, Dreier, J, Hafner, J, Dummer, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070204/
https://www.ncbi.nlm.nih.gov/pubmed/27843579
http://dx.doi.org/10.1136/esmoopen-2015-000003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070204/
https://www.ncbi.nlm.nih.gov/pubmed/27843579
http://dx.doi.org/10.1136/esmoopen-2015-000003

Ejemplares similares